What is SMTI's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.30B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for SMTI?

P/E (TTM) is n/a and 52-week range is $16.05 to $35.52 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s SMTI figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for SMTI?

The company profile lists revenue (TTM) near $116M, net income (TTM) near -$3.40B, EPS (TTM) near -$3.70 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Sanara Medtech Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Fort Worth, Texas, US, 9.2M shares outstanding, ISIN US79957L1008 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Sanara Medtech Inc

$SMTI

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Sanara MedTech, Inc. engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. The company is headquartered in Fort Worth, Texas and currently employs 108 full-time employees. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. The company markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.

Employees

108

Website

sanaramedtech.com/

IPO

1994-04-07

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)